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Background: Long-term complications of sympathomimetic drug overdosing have not been adequately
investigated in infants and young children. Despite reports discouraging their use in children, these formulations
are frequently administered for “cold-like symptoms”. Their frequent adverse events are different forms of
arrhythmias, including multifocal atrial tachycardia.
Case presentation: A 3-year-old toddler developed multifocal atrial tachycardia following an iatrogenic overdose
of epinephrine accidentally administered intravenously. His ECG showed wandering atrial pacemaker (p-waves with
different origins and configurations) that persisted for at least one year. This event demonstrated the sensitivity of
young children to the sympathomimetic drugs, especially overdosing.
Conclusions: Health care providers and parents should be warned of toxicities associated with sympathomimetic
drug overdosing. Future studies are needed to determine whether wandering atrial pacemaker is a potential
long-term complication of high-dose sympathomimetics.
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ArrhythmiaBackground
Sympathomimetic drugs are known to induce arrhyth-
mias, including multifocal atrial tachycardia, re-entry
tachycardia, atrial fibrillation and wandering atrial pace-
maker [1,2]. The mechanism is thought to be due to sinus
node and atrial tissue sensitivity to α- and β-adrenergic
stimuli as well as to decreased cardio-vagal reflex. The
mechanisms involve autonomic transmitters, changes in
impulse formation, conduction and refractoriness [3,4].
Supraventricular tachycardia may induce left ventricular
dysfunction and cardiomyopathy, which are usually
reversible once the tachycardia resolves [5].
Multifocal atrial tachycardia and wandering pacemaker
have already been reported in association with sym-
pathomimetic drug overdosing [2,6]. Multifocal (chaotic)
atrial tachycardia is defined as multiple distinct P-wave
morphologies, irregular P-P intervals and isoelectric
baseline between P-waves with a rapid ventricular rate.
Patients with a wandering atrial pacemaker are usually
asymptomatic and have irregularly irregular rhythm. The* Correspondence: e.aburawi@uaeu.ac.ae
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reproduction in any medium, provided the ornormal heart rate in wandering atrial pacemaker differ-
entiates this condition from multifocal atrial tachycardia
[2,6]. Multifocal atrial tachycardia has been described in
association with respiratory viruses [7]. The fate of the
aberrant atrial electrical activity is unknown.
This report describes a toddler with iatrogenic intra-
venous epinephrine overdose. This accidental exposure
resulted in a lasting wandering atrial pacemaker.
Case presentation
A previously healthy 3-year-old boy (weight 17.5 kg
and height 102.5 cm) presented with viral laryngo-
tracheobronchitis (croup). His initial heart rate was 120
beats per minute (bpm). One milligram epinephrine was
administered via a nebulizer without significant changes
in his heart rate. As respiratory symptoms persisted, a sec-
ond dose of epinephrine (1 mg) was prescribed, but was
inadvertently administered by intravenous push into
a peripheral line. This amount was approximately
6-times the recommended dose (0.01 mg/kg body
weight). The child suddenly developed facial flushing,
tachycardia (187 bpm), hypertension (110/75 mmHg),
hypoxemia (O2 saturation 90% in room air) andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hepatomegaly. Chest x-ray showed increased vascular
markings, which improved after a dose of furosemide.
The child developed multifocal atrial tachycardia with
multiple distinct P-wave morphologies, irregular P-P
intervals, isoelectric baseline between P-waves and rapid
ventricular rate (187 bpm). The QRS complex ≤ 100 ms
and ST-segment elevation ≥ 3 mm were evident on the
rhythm strip (Figure 1, upper panel). Tachycardia per-
sisted for about 12 hours although the wandering pace-
maker persisted after normalization of the heart rate.
This was confirmed on 24-hour Holter tape recording
from 12 to 36 hour after the IV epinephrine administra-
tion; the ventricular rate and QRS duration were normal.
ECG (Figure 1, lower panel) and 24-hour Holter tape
recording at 2, 12 and 18 months showed persistent
wandering pacemaker with normal QRS duration and
ventricular rate (about 100 bpm).
During the acute episode, echocardiogram showed
normal heart structure and ventricular function. Serum
Troponin-T and creatine kinase-MB were also normal.
His vital signs (including heart rate and blood pressure),
O2 saturation and ECG were closely monitored. His
blood pressure normalized 4 hours after the epinephrine
dose. He received a dose of intravenous furosemide and
oxygen supplementation. He was discharged after
48 hours with normal vital signs.
Another cardiac event noted in this patient was an ele-
vated ST-segment (~4 mm, a sign of coronary spasm),
Figure 1.
Fleming et al. have published evidence-based centile
charts from birth to 18 years of age for normal heart rates
[8]. Between 1 and 5 years, the heart rate (mean ± SD) is
109 ± 14 bpm for males and 108 ± 15 bpm for females.
The corresponding values for infants are 132 ±12 bpm
and 135 ± 14 bpm [9]. Thus, the heart rate noted for this
patient (187 bpm) was 5 SD above the mean.Figure 1 ECG findings. Upper panel, rhythm strip (lead II) immediately afte
187 bpm, multifocal atrial tachycardia and ST elevation of 4 mm. Notice th
p-waves are evident (arrows). Lower panel, ECG (leads II and V5) two month
wandering atrial pacemaker. The same findings were present at 12 and 18Children with marked tachycardia (≥4 SD) should be
monitored (vital signs, pulse oximetry and ECG). Serum
troponin-T, serum creatine kinase-MB and chest x-ray
may be necessary based on clinical and ECG findings.
Echocardiography is also needed to rule out underlying
cardiac pathology. Treatment with adenosine, beta-
blockers or calcium-channels blockers should be indivi-
dualised. Therapeutic interventions are justified in symp-
tomatic children (e.g., heart failure, chest pain and
dyspnea), persistent tachy-arrhythmia, ischemic changes
on ECG or abnormal serum cardiac biomarkers. In spe-
cific cases, electrophysiological studies may be necessary
to rule out sinus node re-entry or right atrial tachycar-
dia. Follow-up by a pediatric cardiologist may be neces-
sary, especially in the presence of abnormal ECG.
Conclusions
This report illustrates the potential seriousness of sym-
pathomimetic overdosing. Young children are especially
vulnerable due to high-sensitivity of their sinoatrial node
and atrial tissue to catecholamines. The wandering atrial
pacemaker in this patient could be a long-term conse-
quence, since it persisted at least 18 months after the
incident.
The epinephrine overdose as the cause of his p-wave
abnormality (wandering atrial pacemaker) could not be
confirmed: as he had no ECG prior to the episode, this
finding may have existed before the administration of
epinephrine. We can only speculate that the multifocal
atrial tachycardia present during the acute episode, in-
stead of resolving, persisted and lead to a wandering
atrial pacemaker. This sequel could result from a signifi-
cant damage to the SA-node or atrial tissue, which per-
sisted for at least 18 months.
Sympathomimetics overdosing might be relatively
common in infants and children, since these medications
are frequently used in emergency settings and also atr the intravenous injection of epinephrine, showing a heart rate of
e different P-wave morphologies; flat (junctional), negative and positive
s later showing a ventricular rate of 115 bpm and persistent
months.
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Health care providers and parents should be warned of
toxicities associated with sympathomimetic drugs. Fu-
ture studies are needed to determine whether wandering
atrial pacemaker is a potential long-term complication
of high-dose sympathomimetics.
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